908 Devices Stock (NASDAQ:MASS)
Previous Close
$2.54
52W Range
$1.81 - $7.91
50D Avg
$2.38
200D Avg
$4.18
Market Cap
$81.83M
Avg Vol (3M)
$641.99K
Beta
0.98
Div Yield
-
MASS Company Profile
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
MASS Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Device Sales | $33.38M | - | - |
| Product and service revenue | $49.86M | $16.51M | $14.52M |
| Recurring | $16.48M | - | - |
| Contract | $370.00K | - | - |
| License and contract revenue | - | $2.38M | $1.10M |
| Consumables and service | - | $15.72M | $7.82M |
| Device sales | - | $28.76M | $33.29M |
Fiscal year ends in Dec 23 | Currency in USD
Peer Comparison
| Ticker | Company |
|---|---|
| MDT | Medtronic plc |
| CNMD | CONMED Corporation |
| EW | Edwards Lifesciences Corporation |
| NARI | Inari Medical, Inc. |
| ABT | Abbott Laboratories |
| BSX | Boston Scientific Corporation |
| SYK | Stryker Corporation |
| MGRM | Monogram Orthopaedics, Inc. |
| GKOS | Glaukos Corporation |
| INMD | InMode Ltd. |
| DXCM | DexCom, Inc. |
| BFLY | Butterfly Network, Inc. |
| NVRO | Nevro Corp. |